Advantage Alpha Capital Partners LP Cuts Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Advantage Alpha Capital Partners LP trimmed its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 86.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 58,505 shares of the company’s stock after selling 363,941 shares during the period. Advantage Alpha Capital Partners LP’s holdings in Definitive Healthcare were worth $262,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. 272 Capital LP acquired a new position in Definitive Healthcare during the second quarter worth $3,480,000. Massachusetts Financial Services Co. MA increased its stake in shares of Definitive Healthcare by 36.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after purchasing an additional 1,626,813 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Definitive Healthcare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company’s stock worth $36,600,000 after purchasing an additional 67,068 shares during the last quarter. Boston Partners acquired a new position in shares of Definitive Healthcare during the 1st quarter worth about $550,000. Finally, Marshall Wace LLP purchased a new position in Definitive Healthcare in the 2nd quarter valued at about $1,535,000. 98.67% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have commented on DH. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. Stifel Nicolaus dropped their price target on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a research report on Wednesday, July 31st. JPMorgan Chase & Co. lowered Definitive Healthcare from a “neutral” rating to an “underweight” rating and decreased their price objective for the company from $7.00 to $5.00 in a report on Wednesday, July 31st. Barclays dropped their target price on shares of Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a report on Wednesday, August 7th. Finally, Morgan Stanley decreased their price target on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $5.81.

Definitive Healthcare Trading Up 5.2 %

Shares of DH stock opened at $4.68 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. Definitive Healthcare Corp. has a twelve month low of $3.19 and a twelve month high of $10.62. The company’s 50-day moving average price is $4.35 and its 200-day moving average price is $4.80.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.